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INTRODUCTION: Type 1 diabetes mellitus (T1DM) is caused by autoimmune destruction of insulin-producing beta cells of the pancreas. Islets graft 
transplantation has emerged as a potential strategy for T1DM treatment, but clinical studies show that the insulin independence rate decreased to 20% 
at 5 years post implantation [1]. Progressive islet loss drives the interest to study islet location and function in vivo. Non-invasive imaging methods may 
be used to monitor potential complications after transplantation. Hereby, the quantification of pancreas islets (PIs) mass is of great value for assessing 
islets graft loss post transplantation. MRI has become one of the most promising approaches due to its relative high spatial resolution, the capacity for 
longitudinal assessment, and non-ionizing radiation. The most widely used MR contrast agents for islets labeling are iron oxide based contrast agents, 
which generate hypo-intense signal in T2 and T2* weighted MR images [2]. However, the quantification of PIs in MR images is always challenging due to 
the false positive signal from other sources of hypo-intensity (blood vessels etc.). Alternatively, optical projection tomography (OPT) provides high 
resolution 3D images for non-fluorescent specimens and allows multi-spectral staining for different tissues/cell types that emit specific fluorescence 
signal. The use of OPT for pancreatic islets imaging has been recently demonstrated allowing quantitative assessment of the total islets distribution 
within different lobes of ex vivo pancreas (e.g. [3, 4]). Here, our objective is to cross-validate the labeled pancreatic islets as observed in the OPT and 
MR imaging. To this end, three-dimensional MRI and OPT images were acquired of pancreatic lobes that host PIs labeled with fluorescent tagged iron-
oxide particles. Using spatial normalization methods, we co-registered the multi-modal data, which allowed co-localization of PIs using OPT and MR 
images in a 3D volume. We present the method for cross-validation of the MRI contrast, by using the high-resolution OPT images as gold standard. 
 
METHODS: Pancreatic islets were isolated from mice and labeled with micron-sized iron oxide (MPIOs) particles (ME04F, diameter 1-1.99 μm, 
BangsLab). Labeled islets were injected into a freshly isolated mouse pancreas. Pancreatic lobes were fixed and mounted in agarose prior to OPT 
scanning. Two sequential scans (one for pancreatic tissue (fluorescence channel), one for labeled islets) were performed on a Biophotonics 3001 OPT 
scanner (Bioptonics) using the following settings: rotation degree 0.9 degrees; pixel size 26.3x26.3 μm; resolution 1024x1024 pixels; exposure time 
1000 ms. Subsequently, the phantoms were shipped to the collaborator site for MR imaging. MRI was performed on a 9.4T Biospec small animal MRI 
scanner (Bruker Biospec, Germany), using a quadrature transceiver volume coil with an extra gradient insert. Three-dimensional T2*-weighted gradient 
echo MRI (FLASH) were acquired using the following parameters: TR=100ms, TE=12ms, flip angle 20 degrees, spatial resolution=100μm(isotropic), 
matrix=160×320×160, 6 averages. In order to co-localize the labeled islets in OPT and MR images, high-resolution 3D OPT tissue images were spatially 
normalized to the corresponding 3D MR images. After manual re-orientation and initialization to approximately overlay the multi-modal data, a 12-
parameter affine transformation was determined automatically by maximizing mutual information [4], between MRI and OPT tissue images. This allowed 
visualization of MRI and OPT volumes as 3D overlay, in either MRI or OPT image space. In order to quantitatively asses the PIs, we segmented the 
hypo-intense clusters based on connected component analysis on intensity threshold MRI and OPT images. The minimum cluster size was set to 2 
voxels (in MR image space) and the intensity threshold was adjusted such that almost all of the islets identified in OPT images were co-localized in 
corresponding MR images. The number of clusters identified in 
each of the modalities individually were determined, as well as 
those which were co-localized. By considering OPT as gold 
standard, the false negatives (found only in OPT, but not in MRI) 
and false positives (found only in MRI), were also reported. The 
resulting cluster of PI’s identified in OPT and MRI were rendered 
and color coded. 
 
RESULTS: Qualitative visualization of PI’s from OPT and MRI are 
illustrated from two representative phantoms A and B (see Figure). 
Quantitative measures corresponding to individual and co-
localized clusters are summarized in the Table. The 3D rendering 
of pancreatic tissue (from OPT scans), is overlaid with cluster of 
voxels segmented from MRI (hypointense, in red) and OPT 
channel (islets channel, in green). The co-localized clusters are 
illuminated in yellow color. The magnified views present the extent 
of co-localization. The number of clusters measured in OPT, 
nearly match the actual number of labeled islets within the 
pancreas. The islets that were not noted in our OPT quantification, 
were either outside the pancreas or were not part of the mask 
within which the quantifications were computed. Quantification of 
overlap between signals from OPT with MRI showed about 90% 
agreement of OPT signals with corresponding MRI signals. 
Approximately 85% of MRI signals did not overlap with an OPT 
signal, indicating large numbers of false positive signals in FLASH 
MR images. The accuracy of OPT/MRI co-registration were 
qualitatively assessed at multiple cross-section and deemed 
appreciable for co-localization needs of this application. 
 
DISCUSSION & CONCLUSION: We have demonstrated the 
cross-validation of PI assessment using MRI, by spatially aligning 
the 3D multi-modal pancreatic images from OPT and MRI and objectively assessing clusters of labeled PI’s. While the clusters correspond between OPT 
and MRI, the large number of false positives in MRI is likely explained by 
air bubbles resulting from the phantom preparation. But this would not be 
an issue for future assessment of in vivo MRI studies. In conclusion, 
successful co-registration of PIs from MRI and OPT images allowed 
cross-validation of MR images, confirming its suitability for in vivo PI imaging. This is an essential prerequisite for future validation of in vivo MRI data 
using beta-cell targeting iron oxide based nanoparticles. 
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Figure: Co-localization of pancreatic islets in OPT (green),MRI (red). Overlay (yellow)  
 Labeled OPT MRI Co-localized False -ve False +ve 
Phantom A 21 20 107 18 2 89 
Phantom B 22 16 122 15 1 107 
